Alector, Inc.ALEC

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$1.95
Market cap
$217.7M
P/E
—
Revenue (TTM)
$13.9M
Net income
-$117.9M
Dividend yield
—
1-year total return
-33.4%
Net margin
-850.1%
Revenue growth
-82.9%
Debt / equity
—

What Alector, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$21.1M$207.1M$133.6M$97.1M$100.6M$21.0M
Net income-$190.2M-$36.3M-$133.3M-$130.4M-$119.0M-$142.9M
Free cash flow-$171.8M$295.3M-$24.4M-$186.5M-$231.2M-$184.1M

More on ALEC.

Figures from Alector, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.